Innova Captab Limited has informed the Exchange about Transcript
INNOVACAP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Innova Captab reported Q1 FY26 consolidated revenue of ₹351.5 crores, up 19% year-on-year, with EBITDA rising 28% to ₹56.6 crores and EBITDA margin expanding to 16.1% from 15.1%. PAT grew 5% to ₹31 crores. The company reorganized its business into two verticals: CDMO (71% of revenue at ₹249.5 crores, 8% growth) and Branded Generics (₹101.2 crores, 59% growth). The new Jammu greenfield plant, commercialized in January 2025, generated ₹60 crores in Q1 and is already at operational breakeven at the EBITDA level. Management targets ₹100 crore quarterly revenue from Jammu for PAT breakeven, with product onboarding expected to accelerate in Q3 and Q4. API price declines of up to 20% in key inputs have created near-term pressure, but management aims to retain prior guidance.
Positive for shareholders — strong revenue growth, margin expansion, and a clear ramp-up path for the Jammu plant signal improving earnings power. However, API price volatility and dependence on faster-than-expected product onboarding at Jammu remain near-term watchpoints that could affect growth delivery.